Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis
Open Access
- 1 January 2007
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 13 (23), 3232-6
- https://doi.org/10.3748/wjg.v13.i23.3232
Abstract
To determine the efficacy of tacrolimus on clinical status, histopathological status and biochemical markers in patients with steroid refractory autoimmune hepatitis (AIH). Retrospectively, clinical parameters, biochemistry and histology were obtained from patient records. Nine patients [8 females/1 male, median age 32 (range 16-64) years] were identified to have received tacrolimus for a median duration of 18 (12-37) mo. Before initiation of tacrolimus treatment the patients were maintained on a prednisolone dose of 20 mg daily (range 20-80 mg/d), which was tapered to 7.5 (5-12.5) mg/d (P=0.004). Alanine aminotransferase and immunoglobulin-G concentrations decreased from 154 (100-475) to 47(22-61) U/L (P=0.007), and from 16 (10-30.2) to 14.5 (8.4-20) g/L (P=0.032), respectively. All patients showed improvement of the liver inflammatory activity, as determined by the Ishak score (P=0.016), while the degree of fibrosis tended to decrease (P=0.049). The use of low dose tacrolimus can lead to biochemical and histologic improvement of inflammation with no progression of the stage of fibrosis in patients with steroid refractory AIH. Low dose tacrolimus therapy also allows substantial reduction of prednisone dose.Keywords
This publication has 14 references indexed in Scilit:
- Autoimmune HepatitisNew England Journal of Medicine, 2006
- Efficacy of Tacrolimus in the Treatment of Steroid Refractory Autoimmune HepatitisJournal of Clinical Gastroenterology, 2004
- Decreased fibrosis during corticosteroid therapy of autoimmune hepatitisJournal of Hepatology, 2004
- Current and novel immunosuppressive therapy for autoimmune hepatitisHepatology, 2002
- Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprineJournal of Hepatology, 2000
- International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitisJournal of Hepatology, 1999
- Natural history of liver fibrosis progression in patients with chronic hepatitis CThe Lancet, 1997
- An algorithm for the grading of activity in chronic hepatitis CHepatology, 1996
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial.1995